Inogen (INGN) Capital Expenditures (2013 - 2026)
Inogen (INGN) posted quarterly Capital Expenditures of -$1.5 million for Q1 2026, down 601.03% year-over-year from $292000.0 in Q1 2025, and up 23.64% quarter-over-quarter from -$1.9 million in Q4 2025.
Inogen (INGN) Capital Expenditures (2013 - 2026) Analysis & Trends
Inogen (INGN) has reported Capital Expenditures for 14 consecutive years, with -$1.5 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Capital Expenditures fell 601.03% year-over-year to -$1.5 million; the TTM figure through Mar 2026 stood at -$3.5 million (down 1004.11% YoY), while the FY2025 annual figure was -$1.8 million, down 994.42% from the prior year.
- Capital Expenditures rose to -$1.5 million in Q1 2026 per INGN's latest filing, from -$1.9 million in the prior quarter.
- Across five years, Capital Expenditures topped out at $1.7 million in Q3 2024 and bottomed at -$2.8 million in Q4 2024.
- Historically, Capital Expenditures has averaged -$126000.0 across 5 years, with a median of -$44000.0 in 2023.
- Annual changes were most pronounced in 2022 — Capital Expenditures jumped 3431.71% — and 2024, when it slumped 857.43%.
- Inogen's Capital Expenditures stood at -$89000.0 in 2022, then sank by 232.58% to -$296000.0 in 2023, then plunged by 857.43% to -$2.8 million in 2024, then jumped by 32.39% to -$1.9 million in 2025, then advanced by 23.64% to -$1.5 million in 2026.
- Business Quant data shows INGN's Capital Expenditures at -$1.5 million in Q1 2026, -$1.9 million in Q4 2025, and -$206000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | 497.00 Mn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 202.00 Mn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 488.00 Mn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 195.00 Mn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | 66.90 Mn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | 84.70 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 100.00 Mn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | -74.39 Mn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 87.50 Mn |
| 10 | Inogen | 152.26 Mn | 46.72 Mn | 43.27 Mn | 498,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 498,000.00 |
| Jun 30, 2026 | 498,000.00 |
| Mar 31, 2026 | -1.46 Mn |
| Mar 31, 2026 | -1.46 Mn |
| Dec 31, 2025 | -1.92 Mn |
| Dec 31, 2025 | -1.92 Mn |
| Sep 30, 2025 | -206,000.00 |
| Sep 30, 2025 | -206,000.00 |
| Jun 30, 2025 | 68,000.00 |
| Jun 30, 2025 | 68,000.00 |
| Mar 31, 2025 | 292,000.00 |
| Mar 31, 2025 | 292,000.00 |
| Dec 31, 2024 | -2.83 Mn |
| Dec 31, 2024 | -2.83 Mn |
| Sep 30, 2024 | 1.67 Mn |
| Sep 30, 2024 | 1.67 Mn |
| Jun 30, 2024 | 1.26 Mn |
| Jun 30, 2024 | 1.26 Mn |
| Mar 31, 2024 | 100,000.00 |
| Mar 31, 2024 | 100,000.00 |